首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
【24h】

Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.

机译:甾类化合物作为芳香化酶抑制剂的分子对接和QSAR研究。

获取原文
获取原文并翻译 | 示例
           

摘要

In order to develop more potent, selective and less toxic steroidal aromatase (AR) inhibitors, molecular docking, 2D and 3D hybrid quantitative structure-activity relationship (QSAR) study have been conducted using topological, molecular shape, spatial, structural and thermodynamic descriptors on 32 steroidal compounds. The molecular docking study shows that one or more hydrogen bonds with MET374 are one of the essential requirements for the optimum binding of ligands. The QSAR model obtained indicates that the aromatase inhibitory activity can be enhanced by increasing SIC, SC_3_C, Jurs_WNSA_1, Jurs_WPSA_1 and decreasing CDOCKER interaction energy (ECD), IAC_Total and Shadow_XZfrac. The predicted results shows that this model has a comparatively good predictive power which can be used in prediction of activity of new steroidal aromatase inhibitors.
机译:为了开发更有效,选择性更好和毒性更低的甾体芳香酶(AR)抑制剂,已使用拓扑,分子形状,空间,结构和热力学描述子对分子对接,2D和3D混合定量构效关系(QSAR)进行了研究。 32种甾体化合物。分子对接研究表明,与MET374的一个或多个氢键是配体最佳结合的基本要求之一。获得的QSAR模型表明,可以通过增加SIC,SC_3_C,Jurs_WNSA_1,Jurs_WPSA_1和降低CDOCKER相互作用能(ECD),IAC_Total和Shadow_XZfrac来增强芳香化酶抑制活性。预测结果表明,该模型具有较好的预测能力,可用于预测新型甾体芳香酶抑制剂的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号